SFCM
MIST icon

Seven Fleet Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

Seven Fleet Capital Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Sell
270,233
-63,100
-19% -$101K 0.06% 81
2026
Q1 		$397K Buy
+333,333
New +$584K 0.12% 87

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Seven Fleet Capital Management's MIST Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Milestone Pharmaceuticals (MIST) stake by 19% in Q2 2026, selling an estimated $101K and leaving 270,233 shares worth $362K. The position accounts for 0.06% of the portfolio, ranked #81.

Seven Fleet Capital Management first reported a position in MIST in Q1 2026 and has held it in 2 quarters since. The position peaked at $397K in Q1 2026. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Seven Fleet Capital Management held 270,233 shares of Milestone Pharmaceuticals worth $362K as of Q2 2026.
  • Seven Fleet Capital Management sold 63,100 Milestone Pharmaceuticals shares in Q2 2026, an estimated $101K.
  • Milestone Pharmaceuticals made up 0.06% of Seven Fleet Capital Management's portfolio in Q2 2026, its #81 holding.
  • Seven Fleet Capital Management first reported a position in Milestone Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Milestone Pharmaceuticals position peaked at $397K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.